A GP appointment typically starts with a brief intake: What brings you in? Any chest pain, shortness of breath, recent weight change? Those are reasonable questions for a lot of conditions. They are not designed for perimenopause.
The menopause transition announces itself through a constellation — sleep that fragments in the second half of the night, cycles that shorten then stretch, a temper that fires faster than it used to, a word that's right on the tip of the tongue and won't come. No single symptom is diagnostic. The pattern is.
This article is a working inventory of every domain the menopause transition affects, what the research says is happening in each, and how to present it to a clinician in a way that is hard to dismiss.
Why the standard intake misses perimenopause
Perimenopause is a clinical diagnosis — made from symptoms, menstrual pattern, and age. The STRAW+10 staging system (Harlow et al., J Clin Endocrinol Metab, 2012) defines the menopause transition by menstrual pattern changes — not by a blood test — because FSH (follicle-stimulating hormone) fluctuates so wildly cycle-to-cycle in perimenopause that a single reading is often misleading.
Yet the standard GP intake was not built around this. Kling et al. (Mayo Clin Proc, 2019) found that fewer than 7% of US primary care, internal medicine, and OB/GYN residents felt adequately prepared to manage menopause. Allen et al. (Menopause, 2023) found only 31.3% of US OB/GYN residency programs had a menopause curriculum at all. The training gap is real. Your job is to fill it — with your own symptom record.
The full symptom inventory, by system
What follows is not a checklist to alarm you — it is a map of the documented territory. Most women experience a subset of these, not all of them. The value is in showing you (and your clinician) how many separate-seeming complaints share one hormonal root.
1. Menstrual cycle changes
Cycles that shorten (coming every 24-25 days instead of 28), then begin to skip, lengthen, and become unpredictable. Heavier or lighter flow than usual. Spotting between periods. Clotting. These changes are the STRAW+10 stage markers — they're the clearest calendar signal that the transition has started. Track: cycle start dates, length, flow heaviness (light / moderate / heavy / soaking), and any mid-cycle bleeding.
Important: Heavy bleeding (soaking a pad or tampon hourly for several hours), bleeding more than every 21 days, bleeding between periods, bleeding after sex, or any bleeding after 12 consecutive months of no periods is not typical perimenopause. ACOG recommends evaluation — these patterns need a workup.
2. Vasomotor symptoms (hot flashes and night sweats)
Up to 80% of women experience vasomotor symptoms (VMS) — the sudden heat, flushing, sweating, and rapid heartbeat of a hot flash; the drenching night sweats that force a sheet change at 2 a.m. In the SWAN study, frequent VMS lasted a median of 7.4 years (Avis et al., 2015), with African American women experiencing the longest duration at a median of 10.1 years. Night sweats that disrupt sleep are often the first perimenopause symptom women notice, sometimes before cycle changes. Track: number of hot flashes per 24 hours, severity (mild / moderate / severe), nighttime occurrences.
3. Sleep
Around 40-60% of women in the menopause transition report clinically meaningful sleep disruption (Baker & Driver, Sleep Medicine Reviews, 2018). The dominant pattern is maintenance insomnia — waking in the second half of the night and not getting back down — rather than difficulty falling asleep. This is partly driven by nocturnal hot flashes (many of which women don't consciously feel) and partly by a cortisol curve that begins rising sharply between 3-6 a.m. Track: wake time, estimated hours slept, waking episodes, night sweats, morning energy (1-5 scale).
4. Mood and mental health
SWAN found 2-4x increased odds of high depressive symptoms during the menopause transition versus premenopause (Bromberger et al., 2007/2011). The Harvard Study of Moods and Cycles found that the risk of new-onset major depression — in women with no prior history — roughly doubled during the transition (Cohen et al., Arch Gen Psychiatry, 2006). Irritability, rage disproportionate to the trigger, anxiety, tearfulness, and a low-grade sense of dread or hopelessness are the most commonly reported mood shifts. Women with a history of PMS, PMDD, or postpartum mood symptoms are at highest risk. Track: mood on a simple 1-5 scale (1 = very low, 5 = stable), irritability episodes, anxiety level, any panic.
5. Cognitive symptoms (brain fog)
Greendale et al. (Neurology, 2009) followed 2,362 SWAN women and found that processing speed and verbal memory showed no practice gains during late perimenopause — the expected improvement from repeated testing disappeared — but resumed in postmenopause. Brain fog is real, measurable, and almost always temporary. The domains most affected: word retrieval ("it's right there"), processing speed (slower to take in or act on information), and working memory (losing a thought mid-sentence). Track: subjective cognitive clarity (1-5), specific incidents (forgot what I went upstairs for, lost a word mid-sentence).
6. Genitourinary symptoms (GSM)
Genitourinary syndrome of menopause (GSM) is the umbrella term for vaginal dryness, burning, painful sex, urinary urgency, and recurrent UTIs — all caused by the thinning of estrogen-dependent tissue. Unlike hot flashes, GSM is progressive without treatment. The NAMS 2020 GSM Position Statement notes it affects 27-84% of postmenopausal women, with 84% affected by 6 years post-menopause. Women rarely bring this up; GPs rarely ask. Track: vaginal dryness (yes/no daily), pain during sex (0-10), urgency episodes, UTI episodes in past 3 months.
7. Cardiovascular symptoms (palpitations)
Palpitations — racing, pounding, fluttering, or skipping heartbeats — affect up to 42% of perimenopausal women (Carpenter et al., Menopause, 2022). They are most strongly associated with vasomotor symptoms and anxiety, not with arrhythmia on ECG. They are frequently dismissed or attributed to stress. They are worth reporting, especially to rule out thyroid disease, anemia (common with heavy perimenopausal bleeding), and — when red flags are present — cardiac causes. Track: palpitation episodes (frequency, duration, context), associated symptoms (dizziness, chest pain, shortness of breath).
8. Joint and musculoskeletal changes
Joint pain and stiffness — particularly in the hands, knees, and hips — are commonly reported during the menopause transition. Estrogen has anti-inflammatory effects on joint tissue, and its decline appears to lower the threshold for joint discomfort. This is not the same as inflammatory arthritis, though it can feel similar. Muscle mass also declines (at roughly 0.2% per year, per Greendale et al., JCEM, 2021), increasing the sense of physical vulnerability. Track: joint stiffness (morning, duration), specific joints affected, muscle fatigue.
9. Body composition and weight changes
Greendale et al.'s SWAN body-composition analysis (JCI Insight, 2019) showed fat mass increasing and lean mass decreasing across the menopause transition — independently of chronological aging. Fat shifts from hips and thighs toward the abdomen. BMI doesn't capture this; waist circumference does. Track: waist circumference (weekly if concerned), energy for exercise, subjective changes in strength.
10. "I don't feel like myself"
Coslov et al. (Menopause, 2024) found that 63.3% of midlife women in a survey of 2,400+ endorsed "not feeling like myself" at least half the time — and this experience often preceded visible cycle changes. It is not a diagnosis, but it is a legitimate data point. Write it down and say it out loud to your clinician: "I've felt like a stranger to myself for the past [X] months." That is clinically relevant information.
The two-week log: how to present this to your GP
A single appointment conversation about "feeling off" is easy to dismiss. A two-week daily log is harder to dismiss. It gives your clinician objective data across multiple systems and demonstrates that the symptoms are consistent, not situational.
Track daily for two weeks:
- Cycle: period started (Y/N), flow weight (none / light / moderate / heavy / soaking), spotting
- Hot flashes: number in past 24 hours, severity (mild / moderate / severe)
- Sleep: hours, number of wakings, night sweats (Y/N), morning energy (1-5)
- Mood: overall (1-5), irritability episodes (count), anxiety level (1-5)
- Brain: cognitive clarity (1-5), word-finding incidents (count)
- Body: vaginal dryness / discomfort (Y/N), joint stiffness (Y/N, location), palpitations (Y/N)
Bring the log and say: "Could this be perimenopause? Can we use STRAW+10 staging and a symptom-based approach rather than relying on a single FSH value?" If you can, find a Menopause Society Certified Practitioner at menopause.org — the directory is free and searchable by zip code.
What is and isn't worth testing
A single FSH test is not reliable for diagnosing perimenopause — FSH can vary by an order of magnitude across cycles in the same woman in the same month. The Endocrine Society (Stuenkel et al., JCEM, 2015), NAMS, and ACOG all support symptom-based diagnosis for women in their 40s with a classic symptom pattern. What is worth testing, depending on your symptoms:
- TSH — hyperthyroidism and hypothyroidism both mimic or amplify perimenopausal symptoms
- CBC and ferritin — iron deficiency anemia is common when cycles become heavy; it worsens fatigue, brain fog, and palpitations
- Fasting glucose and lipids — cardiometabolic risk shifts at midlife; useful baseline
- Pregnancy test if relevant — cycles become irregular, ovulation becomes unpredictable